Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Conditions

• Neuromuscular Diseases
• Obesity (Disorder)
• Myotonic Dystrophy 1
• Myasthenic Syndrome
• Charcot Marie Tooth Disease (CMT)
• Glycogen Storage Disease Type II Pompe Disease
• Facio-Scapulo-Humeral Dystrophy
• Myasthenia Gravis
• Huntington Disease
• Progressive Supranuclear Palsy (PSP)
• Hereditary Spastic Paraplegia
• Ataxia, Spinocerebellar

Interventions

• DEVICE: Syde
• DIAGNOSTIC_TEST: Dynamometric measurements of muscle strength
• DIAGNOSTIC_TEST: The 6-minute walk test (6MWT)
• DIAGNOSTIC_TEST: The 10-meter test (10MWT)
• DIAGNOSTIC_TEST: The 4 stair-climbing test (4SC)
• DIAGNOSTIC_TEST: Test of rising from the floor (TRF)
• DIAGNOSTIC_TEST: The Timed up and go test (TUG)
• DIAGNOSTIC_TEST: The Progressive Supranuclear Palsy Rating Scale (PSP-RS)
• DIAGNOSTIC_TEST: The Montreal Cognitive Assessment (MOCA)
• DIAGNOSTIC_TEST: The Charcot-Marie-Tooth examination score (CMTES)
• DIAGNOSTIC_TEST: 9-Hole Peg Test (9-HPT)
• DIAGNOSTIC_TEST: The Unified Huntington's Disease Rating Scale (UHDRS)
• DIAGNOSTIC_TEST: Quantitative Myasthenia Gravis (QMG)
• DIAGNOSTIC_TEST: The Myasthenia Gravis Activities of Daily Living Scale (MG-ADL)
• DIAGNOSTIC_TEST: The Scale for the Assessment and Rating of Ataxia (SARA)
• OTHER: Patient's Global Impression of Change (PGIC)

Sponsor

Centre Hospitalier Universitaire de Liege

Collaborators

• [object Object]
• [object Object]